Evaluating the NHS research and development programme: will the programme give value for money?

Peckham M. Evidence to the House of Lords Select Committee on Science and Technology. In: Medical Research and the NHS Reforms, HL Paper 12–1, Session 1994–1995. London: HMSO, 1994.

Buxton M. , Hanney S. How can payback from health services research be assessed? J Health Serv Res Policy 1996; 1: 35–43.

Buxton M. , Hanney S. Assessing Payback from Department of Health Research and Development: Preliminary Report: Main Report, Vol. 1. HERG Research Report No. 19. Uxbridge: Health Economics Research Group, Brunel University, 1994.

Buxton M. , Hanney S. Assessing Payback from Department of Health Research and Development: Second Report: Main Report, Vol. 1. HERG Research Report No. 24. Uxbridge: Health Economics Research Group, Brunel University, 1997.

Peckham M. Research and development for the National Health Service. Lancet 1991; 338: 367–71.

Company Reporting. The 1997 UK R&D Scoreboard. London: Department of Trade and Industry, 1997.

Office of Science and Technology and Programme for Policy Research in Engineering Science and Technology. Returns to Research and Development Spending. London: HMSO, 1993.

Martin B. , Slater A. The Relationship Between Publicly Funded Basic Research and Economic Performance. A Science Policy Research Unit report for H M Treasury. Brighton: SPRU, University of Sussex, 1996.

Swann P. The Economic Value of Publicly Funded Basic Research: a Framework For Assessing the Evidence. A report for DTI, Manchester: Policy Research in Engineering, Science and Technology, University of Manchester, 1996.

National Institutes of Health. Cost Savings Resulting from NIH Research Support, 2nd edn. Bethesda: NIH, 1993.

Detsky A. Are clinical trials a cost-effective investment? JAMA 1989; 262: 1795–800.

Robertson D. Ex-post Evaluation of Selected Transport Research Projects. Research Report No. 86. Crowthorne: Transport Research Laboratory, 1995.

Department of Health. Policy Appraisal and Health. London: Department of Health, 1995.

Anderson J. New Approaches to Evaluation in UK Research Funding. Concept paper No. 9. London: Science Policy Support Group, 1989.

Cave M. , Hanney S. , Kogan M. , Trevett G. The Use of Performance Indicators in Higher Education. London: Jessica Kingsley, 1988.

Commission of the European Communities. Patents as Indicators of the Utility of European Community R and D Programmes. Luxembourg: Office for Official Publications of the European Community, 1991.

Chalmers I. Assessing the Effects of Health Technologies. Report from the advisory group on health technology assessment chaired by Iain Chalmers. London: Department of Health, 1992.

Rosenburg N. Why do firms do basic research (with their own money). Res Policy 1990; 19: 165–74.

Gambardella A. Competitive advantages from in-house scientific research: the US pharmaceutical industry in the 1980s. Res Policy 1992; 21: 391–407.

Cave M. , Burningham D. , Buxton M. , Hanney S. , Pollitt C. , Scanlan M. The Valuation of Changes in Quality in the Public Services. London: HMSO, 1994.

MMI Group. Making NHS R&D Pay: The Culyer Report and Beyond, NAHAT Update. Birmingham: NAHAT, 1995.

Mansfield E. Academic research and industrial innovation. Res Policy 1991; 20: 1–12.

Smith K. Economic Returns to R&D: Methods, Results and Challenges, Review Paper No. 3. London: Science Policy Support Group, 1991.

Mushkin S. Biomedical Research: Costs and Benefits. Cambridge, MA: Callinger, 1979.

Weisbrod B. Economics and Medical Research. Washington DC: American Enterprise Institute, 1983.

Koopmanschap M. , Rutten F. Indirect costs in economic studies: confronting the confusion. PharmacoEconomics 1993; 4: 446–54.

Buxton M. , Elliott R. , Hanney S. , Henkel M. , Keen J. , Sculpher M. Assessing Payback from Department of Health Research and Development: Preliminary Report: Eight Case Studies, Vol. 2. HERG Research Report No. 19. Uxbridge: Health Economics Research Group, Brunel University, 1994.

Hanney S. , Buxton M. eds. Assessing Payback from Department of Health Research and Development: Second Report: Ten Further Case Studies, Vol. 2. HERG Research Report No. 24. Uxbridge: Health Economics Research Group, Brunel University, 1997.

Department of Health. Methods to Promote the Implementation of Research Findings in the NHS—Priorities For Evaluation. London: Department of Health, 1995.